Shahrokh F Shariat

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersInstruments and techniquesNephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2023
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo

|May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo

|Mar 24, 2020
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy.

Giuseppe Rosiello, Carlotta Palumbo, Sophie Knipper

|Jan 12, 2020
The effect of focus size and intensity on stone fragmentation in SWL on a piezoelectric lithotripter.

Julian Veser, Victoria Jahrreiss, Christian Seitz

|Nov 06, 2019
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies.

Elio Mazzone, Francesco A Mistretta, Sophie Knipper

|Mar 30, 2016
Comparison of silodosin to tamsulosin for medical expulsive treatment of ureteral stones: a systematic review and meta-analysis.

Mehmet Özsoy, Evangelos Liatsikos, Nicolas Scheffbuch

Pageof 1

Frequent Collaborators

2 joint publications

Mike Wenzel

2 joint publications

Luigi Nocera

2 joint publications

Claudia Collà Ruvolo

2 joint publications

Christoph Würnschimmel